Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Cash from Financing Activities (2024 - 2025)

Hinge Health's Cash from Financing Activities history spans 2 years, with the latest figure at -$79.5 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 3306.64% year-over-year to -$79.5 million; the TTM value through Dec 2025 reached -$81.4 million, changed N/A, while the annual FY2025 figure was -$150.5 million, 6733.24% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$79.5 million at Hinge Health, down from $531000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $531000.0 in Q3 2025 and bottomed at -$79.5 million in Q4 2025.